Biodefense

Both the United States Department of Defense and the Department of Health and Human Services have interests in technologies providing a rapid and robust response to environmental and bioterror threats, such as influenza and anthrax. The Pfēnex Expression Technology^TM platform provides a solution to these threats and meets the stringent demands of rapid response and cost. Current contracts and subcontracts total more than $20 million.